INSIGHTS ON CLINICAL TRIAL DESIGN

• Cell And Gene Therapy Field Quiet In Q2

  While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.

• From Chaos To Clarity: A Founder's View From 30 Years In Drug Development

  Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.

• Accelerating IND-Enabling Studies With Automated Bioanalysis Workflows

  Reimagined as automation-first, bioanalysis shifts from being an Investigational New Drug (IND) bottleneck to a catalyst for innovation—helping companies move therapies forward with greater confidence.

• Modernizing Clinical Research With Patient-Centric Digital Data Collection

  Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.

• Optimizing Clinical Supply Flexibility With Demand-Led Strategies

  3/24/2026

  Explore demand-led supply strategies for clinical trials. Compare traditional vs. DLS models and learn when pack-to-order, pack-to-stock, or hybrid approaches optimize supply flexibility.

• Dedicated Community Oncology Sites

  7/29/2026

  Rapid activation, strong referral partnerships, diverse patient access, and specialized immunotherapy infrastructure are reshaping oncology research.

• The Impact Of Expert PK/PD Modeling In Psychedelic Research

  12/2/2025

  Model-informed development that integrates preclinical and literature-based data is enabling smarter predictions of exposure and safety, transforming psychedelic research and advancing clinical innovation.

• Critical Imaging Risks In GLP-1 And Neurology Studies

  5/27/2025

  As imaging grows in importance within GLP-1 and neurology trials, it must be treated not as a routine task but as a strategic pillar that supports participant safety and reproducible outcomes.

• Accelerating Oncology Drug Development Through Innovative Designs

  3/30/2026

  Adaptive and novel trial designs are redefining oncology development, powering faster decisions with smarter flexibility. Discover innovative approaches that elevate efficiency while safeguarding scientific rigor.